RESUMEN
Rhabdomyosarcoma is a malignant tumor of striated muscle tissue that can exceptionally present in the pleura. Its prognosis is generally poor. We report a case of an eight-year-old child admitted for a persistent dry cough which had progressed for three weeks, complicated by breathing difficulties and a deterioration in general condition. He had a history of recent contact with an uncle with pulmonary tuberculosis. Clinical examination on admission revealed right pleural effusion syndrome with moderate respiratory repercussion. The biological assessment shows moderate inflammation and a very high level of lactate dehydrogenase (LDH). Radiologically, there was abundant right pleurisy with intra-pleural nodular masses without ipsilateral pulmonary invasion or other distant localization. Pleural puncture reveals exudative lymphocytic fluid with negative tuberculous polymerase chain reaction (PCR) and atypical cells in cytology. Biopsy of the pleural mass showed pleural rhabdomyosarcoma of the alveolar type. The pet scan found bone metastases at two costal arches. After conditioning, the child received several courses of chemotherapy. The clinical and radiological outcome was favorable. This case is reported in view of its rarity and originality. We conclude that early diagnosis and treatment greatly improves the prognosis of this aggressive tumor.
Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/prevención & control , Trasplante de Células Madre Hematopoyéticas/métodos , Control de Infecciones/métodos , Pandemias/prevención & control , Neumonía Viral/prevención & control , Guías de Práctica Clínica como Asunto , Cuidados Posteriores , COVID-19 , Infecciones por Coronavirus/epidemiología , Europa (Continente) , Enfermedades Hematológicas/terapia , Trasplante de Células Madre Hematopoyéticas/normas , Humanos , Higiene , Inmunoterapia Adoptiva , Control de Infecciones/normas , Marruecos/epidemiología , Neoplasias/terapia , Neumonía Viral/epidemiología , SARS-CoV-2 , Sociedades Médicas , Sociedades Científicas , Donantes de Tejidos , Estados Unidos , Organización Mundial de la SaludRESUMEN
Thrombocytopenia is a common hematologic disorder in the neonatal period. It can occur in neonates hospitalized in the Intensive Care Unit and in preterm infants. It is characterized by a platelet count of less than 150.000/mm3. In the context of immune thrombocytopenia, neonatal thrombocytopenia due to maternal alloimmunization (estimated at 1 per 1000 live births) is not a rare event but it is often undiagnosed in minor forms. This is caused by maternal immunization against fetal platelet antigens inherited from the father and lacking in the mother. Maternal IgG alloantibodies cross the placenta causing fetal platelet destruction. In severe thrombocytopenia, consequences can be severe, with intracranial bleeding occurring in 10-30% of patients. Diagnosis is essentially based on clinical examination and must be suspected by pediatricians.
Asunto(s)
Antígenos de Plaqueta Humana/inmunología , Isoanticuerpos/inmunología , Trombocitopenia Neonatal Aloinmune/diagnóstico , Adulto , Femenino , Sangre Fetal/inmunología , Humanos , Inmunoglobulina G/inmunología , Recién Nacido , Masculino , Embarazo , Índice de Severidad de la Enfermedad , Trombocitopenia Neonatal Aloinmune/inmunologíaRESUMEN
The survival rate improvement of childhood cancer survivors lead to question about their educational and social outcome. Authors suggest an international review in order to find risk factors of school or social failure after cancer experience. Principal cohort is studied in USA (the Children Cancer Survivor Study). Nevertheless, European studies are also published. The results vary, depending on subpopulation studied and on control choice (siblings or general population). Treatment improvement and supportive care make difficult to compare studies with current situations. Moreover, there are not international standard of education or social outcome. School and social behaviour are influenced by: types of tumor (cerebral tumor but also sometimes hemopathy and osteosarcoma), age at diagnosis (very young children and adolescent), treatments (neurotoxical treatments, hematopoietic stem cell transplant), and social or educational status of the parents.